ArticleTalanta2026
Rapid quantitation of erythropoietin and identification of its glycans using membranes for capture and digestion.
Article in Talanta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Erythropoietin (EPO) is a glycoprotein hormone used to treat chronic anemia. Glycans at the three N-glycosylation sites strongly influence EPO's stability and bioactivity, so accurate quantitation of EPO and analysis of its glycosylation patterns are critical during production and subsequent processing. This work demonstrates a rapid workflow for EPO capture, quantitation, and glycan profiling. Newly developed porous membranes containing affinity peptides selectively capture EPO from cell culture supernatants. In a 96-well-plate format, captured EPO was labeled with a fluorescent antibody to enable quantitation in a 10-min assay with an average coefficient of variation of 12 %. Elution of captured EPO from a 2-cm glass-fiber membrane combined with tryptic membranes enabled efficient purification and digestion for liquid chromatography-tandem mass spectrometry (LC-MS/MS) glycan analysis. Without purification, conventional LC-MS/MS identification of EPO N-glycans in Chinese hamster ovary (CHO) cell supernatant was not possible. The rapid in-membrane digestion yielded glycan profiles comparable to those obtained from overnight in-solution digestion. Thus, the membrane-based assays provide a novel approach for rapid EPO quantitation and facilitating glycan identification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.